These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 75921)

  • 21. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
    Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
    Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid factors may bear the internal image of the Fc gamma-binding protein of herpes simplex virus type 1.
    Tsuchiya N; Williams RC; Hutt-Fletcher LM
    J Immunol; 1990 Jun; 144(12):4742-8. PubMed ID: 2161877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the inactivation of IgM and IgG complement fixation sites by acid and base.
    Stollar BD; Stadecker MJ; Morecki S
    J Immunol; 1976 Oct; 117(4):1387-91. PubMed ID: 10334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition.
    Nishi H; Miyajima M; Wakiyama N; Kubota K; Hasegawa J; Uchiyama S; Fukui K
    J Biosci Bioeng; 2011 Oct; 112(4):326-32. PubMed ID: 21783411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunoglobulin-binding Eib proteins from Escherichia coli are receptors for IgG Fc.
    Leo JC; Goldman A
    Mol Immunol; 2009 May; 46(8-9):1860-6. PubMed ID: 19303642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions.
    Chan LA; Phillips ML; Wims LA; Trinh KR; Denham J; Morrison SL
    Mol Immunol; 2004 Jul; 41(5):527-38. PubMed ID: 15183931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary studies on involvement of alpha-1-glycoprotein in the reaction of IgG-3 with leukocytes.
    Wróblewski Z
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):413-21. PubMed ID: 3439853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential mapping of Fc gamma-binding and monoclonal antibody-reactive epitopes on gE, the Fc gamma-binding glycoprotein of herpes simplex virus type 1.
    Williams RC; Kievit E; Tsuchiya N; Malone C; Hutt-Fletcher L
    J Immunol; 1992 Oct; 149(7):2415-27. PubMed ID: 1382102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
    McCool D; Birshtein BK; Painter RH
    J Immunol; 1985 Sep; 135(3):1975-80. PubMed ID: 3860563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding characteristics of human hybridoma IgG and IgM rheumatoid factors: influence of IgG isotype and carbohydrate content.
    Newkirk MM; Rauch J; Commerford K
    J Rheumatol Suppl; 1992 Jan; 32():54-5; discussion 55-8. PubMed ID: 1613734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of acid alpha 1-glycoprotein with immunoglobulins.
    Wróblewski Z
    Acta Biochim Pol; 1981; 28(1):21-30. PubMed ID: 7282213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pH on the binding between guinea pig IgG isotypes and protein A: evidence for intra-isotypic binding heterogeneity.
    Ricardo MJ; Trouy RL; Grimm DT
    J Immunol; 1981 Sep; 127(3):946-51. PubMed ID: 7264306
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of pH and ionic strength on IgG adsorption to vials.
    Mathes J; Friess W
    Eur J Pharm Biopharm; 2011 Jun; 78(2):239-47. PubMed ID: 21421047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular insight into the ligand-IgG interactions for 4-mercaptoethyl-pyridine based hydrophobic charge-induction chromatography.
    Lin DQ; Tong HF; Wang HY; Yao SJ
    J Phys Chem B; 2012 Feb; 116(4):1393-400. PubMed ID: 22214397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the mechanism of interaction of antibody (IgG) on two mixed mode sorbents.
    Ranjini SS; Bimal D; Dhivya AP; Vijayalakshmi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1031-7. PubMed ID: 20362518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of immunoglobulin G to peripheral blood lymphocytes.
    Hajela K; Salahuddin A
    Immunol Lett; 1988 Oct; 19(2):159-62. PubMed ID: 2976735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid optimization of immunoadsorbent characteristics.
    Janatova J; Gobel RJ
    Biochem J; 1984 Jul; 221(1):113-20. PubMed ID: 6380495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of altered glycosylation of IgG on rheumatoid factor-binding and immune complex formation.
    Soltys AJ; Bond A; Westwood OM; Hay FC
    Adv Exp Med Biol; 1995; 376():155-60. PubMed ID: 8597243
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosorbent for IgG apheresis: an in vitro study.
    Kiseleva EA; Afanasieva OI; Kosheleva NA; Pokrovsky SN
    Transfus Sci; 1996 Dec; 17(4):519-25. PubMed ID: 10168549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-based immunoadsorbents: molecular grafting of IgG-Fc-binding epitopes of Protein A onto a de novo-designed helix-loop-helix peptide.
    Kawabata K; Nagai H; Konishi N; Fujiwara D; Sasaki R; Ichikawa T; Fujii I
    Bioorg Med Chem; 2014 Mar; 22(6):1845-9. PubMed ID: 24556503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.